.ALX Oncology's phase 2 stomach cancer cells response cost has deteriorated. After viewing its CD47 ...
.One More of Ionis Pharmaceuticals' key midphase readouts has fallen short of requirements, urging t...
.While Biogen's pharma peers are actually seeking for late-stage properties along with little bit of...
.Instil Bio has been a biotech trying to find a pipe after it ditched its own lead possessions over ...
.Biogen has returned legal rights to a very early Alzheimer's condition system to Denali Therapies, ...
.Invite to today's Chutes & Ladders, our roundup of significant management hirings, firings and a...
.Vertex's try to deal with an unusual genetic ailment has struck another obstacle. The biotech tosse...
.Vir Medical's second-quarter earnings document had not been short of big information. The business ...
.Galapagos has actually paused application in a test of a BCMA-directed CAR-T tissue treatment, push...
.After more than thirty years, genetics therapy trailblazer James Wilson M.D., Ph.D., is actually le...